title: Modulation of the effect of anthracycline efficacy and toxicity by ICRF-187.
authors.affiliation: Division of Medical Oncology, Kaplan Cancer Center, New York University Medical Center, New York 10016.
authors.forename: R H
authors.initials: RH
authors.lastname: Blum
authors.forename: C
authors.initials: C
authors.lastname: Walsh
authors.forename: M D
authors.initials: MD
authors.lastname: Green
authors.forename: J L
authors.initials: JL
authors.lastname: Speyer
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000009:adverse effects; D004317:Doxorubicin / Q000008:administration & dosage / Q000009:adverse effects; D004357:Drug Synergism; D005472:Fluorouracil / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D010879:Piperazines / Q000008:administration & dosage*; D016032:Randomized Controlled Trials as Topic; D011929:Razoxane / Q000008:administration & dosage*
chemical_list: D010879:Piperazines; D011929:Razoxane; D004317:Doxorubicin; D003520:Cyclophosphamide; D005472:Fluorouracil